Push reforms to improve prescription drug price transparency and increase access to more affordable generic medications.

In addition, I am pushing for reforms to make improvements in price transparency and increase access to more affordable generic medications.

Commits to pursuing reforms on drug pricing transparency and generic drug access.

Chrissy Houlahan For U.S. Congress
campaign · campaign_site · model gpt-5.4-mini

Representative Chrissy Houlahan voted to pass H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, and said, “I promised my community that I would fight to lower the high cost of prescription drugs.” She described the bill as making prescription drugs more affordable and said it would create requirements and incentives to expand protections and lower prices across the market.

Official statement tying Houlahan to a vote for a major drug-pricing reform package that included broader affordability and market-wide price-lowering measures.

partial same_term A for effort

Houlahan takes aim at lowering prescription drug prices
secondary · model gpt-5.4-mini · confidence 93%

The House-passed H.R. 3 required HHS to negotiate prices for certain drugs, including single-source brand-name drugs that do not have generic competition, and it included a drug price transparency title requiring manufacturers to report specified information for certain high-cost drugs.

Official bill summary showing the transparency and generic-competition components of the drug-pricing reform Houlahan publicly supported.

partial same_term A for effort

H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
secondary · model gpt-5.4-mini · confidence 97%

Houlahan said the Build Back Better Act would, “for the first time in history,” empower the government to negotiate lower drug prices under Medicare, cap out-of-pocket spending at $2,000, and require drug companies to pay rebates if prices increase faster than inflation.

Official statement that Houlahan supported a package containing major prescription-drug pricing reforms, including negotiation and inflation rebates.

partial later_term A for effort

Houlahan Votes to Lower the Cost of Health Care, Housing and Child Care, Passes Build Back Better Act
secondary · model gpt-5.4-mini · confidence 95%

Houlahan said the Inflation Reduction Act, signed into law in 2022, included cost-saving provisions helping Pennsylvanians save on health care bills. The page says the law allows Medicare to negotiate directly with pharmaceutical companies for fair prices for prescription drugs and that out-of-pocket drug costs will be capped at no more than $2,000 in 2025.

Official evidence that a major drug-price reform Houlahan backed became law and is now producing consumer savings.

partial later_term

Houlahan Welcomes U.S. Secretary of Health and Human Services to Discuss Consumer Savings with Lower Cost Prescription Drug Law
secondary · model gpt-5.4-mini · confidence 98%

CMS stated that, “For the first time, the law provides Medicare the ability to directly negotiate the prices of certain high expenditure, single source drugs without generic or biosimilar competition,” and that the negotiated prices would go into effect January 1, 2026, producing an estimated $1.5 billion in savings for people with Medicare Part D coverage.

Official federal confirmation that the enacted reform is in force and targets high-cost drugs without generic or biosimilar competition, with concrete savings.

partial later_term

Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026
secondary · model gpt-5.4-mini · confidence 96%